Immunosuppression with ALG and CsA is first line treatment in children with SAA lacking an HLA identical sibling

This publication has 11 references indexed in Scilit:

• Acquired severe aplastic anemia in children: Is there a standard of care?
  Pediatric Blood & Cancer, 2004
• Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia
  Blood, 2003
• Late complications following treatment for severe aplastic anemia (SAA) with high-dose cyclophosphamide (Cy): follow-up of a randomized trial
  Blood, 2002
• Durable Treatment-Free Remission after High-Dose Cyclophosphamide Therapy for Previously Untreated Severe Aplastic Anemia
  Annals of Internal Medicine, 2001
• High-dose cyclophosphamide in severe aplastic anaemia: a randomised trial
  The Lancet, 2000
• Treatment of acquired severe aplastic anemia: Bone marrow transplantation compared with immunosuppressive therapy-the European group for blood and marrow transplantation experience
  Seminars in Hematology, 2000
• Treatment of aplastic anaemia (AA) with antilymphocyte globulin (ALG) and methylprednisolone (MPred) with or without androgens: a randomized trial from the EBMT SAA working party
  British Journal of Haematology, 1993
• Multicenter randomized study comparing cyclosporine-A alone and antithymocyte globulin with prednisone for treatment of severe aplastic anemia
  Blood, 1992
• Treatment of Aplastic Anemia with Antilymphocyte Globulin and Methylprednisolone with or without Cyclosporine
  New England Journal of Medicine, 1991
• Antithymocyte Globulin Treatment in Patients with Aplastic Anemia
  New England Journal of Medicine, 1983